Month: December 2011
-
PhRMA: 88 HIV/AIDS Meds in Development at U.S. Companies
A report by Pharmaceutical Research and Manufacturers of America (PhRMA) says U.S. biopharmaceutical companies are testing 88 medicines and vaccines to treat or prevent HIV/AIDS and related conditions. The report, issued on World AIDS Day (1 December 2011), also lists 36 currently approved medications for HIV infection and AIDS. According to PhRMA’s report, more than…
-
Research Project to Develop Salad Vegetable Safety Science
A new research initiative aims to provide U.S. growers and industry with the scientific basis to answer questions about the safety of salad vegetables. The research, led by University of Maryland food science professor Robert Buchanan, will conduct tests and collect data to develop safe and hygienic practices in farming, packing, transporting, and storing fresh…
-
Trial Shows Safety of Engineered Gene Therapy
In an early-stage clinical trial, researchers at University of North Carolina in Chapel Hill have demonstrated the safety of creating a genetically-engineered virus to treat a form of muscular dystrophy. The findings of pharmacologist Jude Samulski (pictured left) and colleagues are reported online in the journal Molecular Therapy; paid subscription required. With gene therapy, a…
-
U.S., China Patent Offices to Begin Reciprocity Tests
The patent offices of the U.S. and China are set to begin today pilot programs of reciprocity agreements to reduce the duplication of patent examinations between the two countries. The U.S. Patent and Trademark Office (USPTO) and China’s State Intellectual Property Office (SIPO) agreed last month to hold these one-year pilot tests. Under the agreement…